Pre-treatment disease trajectories in severe asthma impact treatment-related outcomes, according to a study by Johannes ...

Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Cole Schmidtknecht, of Wisconsin, USA, struggled to breathe after a severe asthma attack and became asphyxiated after ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

Cory Schmidtknecht's family is demanding damages from Walgreens Pharmacy and United Health Group's OptumRx for their alleged ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...